A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
To investigate efficacy, safety and pharmacokinetics of adalimumab subcutaneous (sc) for Japanese subjects with intestinal Behçet's disease who are refractory to conventional therapies.
Inclusion Criteria:
Exclusion Criteria:
Nishinomiya-shi, Japan
Sagamihara-shi, Japan
Takatsuki-shi, Japan